After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, SRPT falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Sarepta Therapeutics Inc is $5.97B. A total of 1.16 million shares were traded on the day, compared to an average of 1.92M shares.
In the most recent transaction, Nicaise Claude sold 2,491 shares of SRPT for 99.64 per share on Mar 12 ’25. After the transaction, the Director now owns 27,812 company shares. In a previous transaction on Mar 12 ’25, Nicaise Claude bought 2,491 shares at 99.65 per share.
Among the insiders who sold shares, Wigzell Hans Lennart Rudolf disposed of 10,500 shares on Dec 12 ’24 at a per-share price of $124.84. This resulted in the Director holding 22,840 shares of SRPT after the transaction. In another insider transaction, Wigzell Hans Lennart Rudolf bought 10,500 shares at $124.80 per share on Dec 12 ’24.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SRPT has a high of $173.25 and a low of $48.01.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $15.77, while its Total Shareholder’s Equity was $928.01M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 4.63.
